Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?

To: musicguy who wrote (4593)	6/5/1998 11:39:00 AM
From: Leman	Respond to of 25711

GLGC does not seem to be a drug discovery type company. One may not expect a Via(ble O)gra from GLGC. It may not produce a surprise disappointment. GLGC may be based on computer applications to bioresearch, information gathering and making it user friendly. When their OPM can mesmerize SmithKline, sure we can expect some more giants. I speculate a steady growth ahead. It may be a potential target for one of those collaboraters (Organon ?). As ASTRA does in Walthem, MA, GLGC may be one way for Organon to tape US bioinformatics research potential rather than licensing for GLGC products. Will it be a gene analysis/discovery company or bioinformatics data base company? When theirEither way it is a growing company in a potential field. Refer to Deepa Pakianathan's message. Is GLGC going to make a Flo-thru chip? A chip to analyse a chimp? Interesting! I would play with a chimp. Now may be a good time to accumulate some shares. Long term investers may buy it now ( 6 )and put it on sale for 11 7/8 (98% gain).